adamantane has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Elhameed, AG; Helal, MG; Said, E; Salem, HA | 1 |
| Beljanski, V; Lewis, CS; Smith, CD | 1 |
2 other study(ies) available for adamantane and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: A novel suppressive impact on Wnt/Hedgehog/Notch1 signaling.
Topics: Adamantane; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Hedgehog Proteins; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Rats, Sprague-Dawley; Receptor, Notch1; Thioacetamide; Wnt Signaling Pathway | 2021 |
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Flow Cytometry; Hep G2 Cells; Humans; Liver Neoplasms; Lysophospholipids; Mice; Mitogen-Activated Protein Kinases; Niacinamide; Phenylurea Compounds; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Sorafenib; Sphingosine; Xenograft Model Antitumor Assays | 2011 |